IONS News and Press, Ionis Pharmaceuticals Inc. From 05/09/24

2024-05-09 06:30:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Here’s a question for you: What determines the value of a drug ? Is it the number of lives it saves or how much it costs to make? Is it the deadliness of the disease it prevents or t...

2024-05-07 17:39:09 ET Ionis Pharmaceuticals, Inc. (IONS) Q1 2024 Results Conference Call May 07, 2024 11:30 AM ET Company Participants Wade Walke - SVP of IR Brett Monia - CEO Kyle Jenne - Chief Global Product Strategy Officer Beth Hougen - CFO Richard G...

2024-05-07 07:05:18 ET More on Ionis Pharmaceuticals Ionis Pharmaceuticals 2023 Earnings Review: Short-Term Pain, Long-Term Gain Ionis Pharmaceuticals, Inc. 2023 Q4 - Results - Earnings Call Presentation Ionis Pharmaceuticals, Inc. (IONS) Q4 2023 Earnings Call Transc...

Aterian Inc. (ATER) is expected to report for Q1 2024 Dorman Products Inc. (DORM) is expected to report $0.82 for Q1 2024 Hillman Solutions Corp. (HLMN) is expected to report $0.08 for Q1 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2024-03-31 Inn...

Ionis reports first quarter 2024 financial results PR Newswire WAINUA TM launch on track; EU and Canada approval decisions expected this year Olezarsen NDA submitted to FDA for FCS; preparing EU regulatory submission Positive Phase 3 donidalorse...

2024-05-06 10:55:22 ET More on Ionis Pharmaceuticals Ionis Pharmaceuticals 2023 Earnings Review: Short-Term Pain, Long-Term Gain Ionis Pharmaceuticals, Inc. 2023 Q4 - Results - Earnings Call Presentation Ionis Pharmaceuticals, Inc. (IONS) Q4 2023 Earnings Call Transc...

2024-05-02 13:46:08 ET More on Metagenomi, Inc. Stocks To Watch: Eyes On Broadcom, Target, Costco, Rivian And Small Caps Metagenomi, Moderna terminate gene editing collaboration Jefferies, BMO bullish on newly public Metagenomi Historical earnings data for Me...

2024-05-02 05:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Ionis to hold first quarter 2024 financial results webcast PR Newswire Webcast scheduled for Tuesday, May 7 at 11:30 a.m. Eastern Time CARLSBAD, Calif. , April 23, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced toda...

2024-04-19 17:10:14 ET More on ContraVir Seeking Alpha’s Quant Rating on ContraVir Historical earnings data for ContraVir Financial information for ContraVir Read the full article on Seeking Alpha For further details see: Hepion ends Phase ...